Erste Asset Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,000
| Closed | -$215K | – | 724 |
|
|
2024
Q3 | $215K | Hold |
11,000
| – | – | ﹤0.01% | 478 |
|
|
2024
Q2 | $226K | Hold |
11,000
| – | – | ﹤0.01% | 475 |
|
|
2024
Q1 | $233K | Hold |
11,000
| – | – | ﹤0.01% | 472 |
|
|
2023
Q4 | $157K | Hold |
11,000
| – | – | ﹤0.01% | 490 |
|
|
2023
Q3 | $96.5K | Hold |
11,000
| – | – | ﹤0.01% | 501 |
|
|
2023
Q2 | $113K | Hold |
11,000
| – | – | ﹤0.01% | 515 |
|
|
2023
Q1 | $130K | Hold |
11,000
| – | – | ﹤0.01% | 522 |
|
|
2022
Q4 | $135K | Hold |
11,000
| – | – | ﹤0.01% | 524 |
|
|
2022
Q3 | $146K | Hold |
11,000
| – | – | ﹤0.01% | 510 |
|
|
2022
Q2 | $200K | Hold |
11,000
| – | – | ﹤0.01% | 512 |
|
|
2022
Q1 | $177K | Sell |
11,000
-47,000
| -81% | -$756K | ﹤0.01% | 511 |
|
|
2021
Q4 | $850K | Hold |
58,000
| – | – | 0.02% | 376 |
|
|
2021
Q3 | $1.09M | Hold |
58,000
| – | – | 0.02% | 331 |
|
|
2021
Q2 | $1.25M | Hold |
58,000
| – | – | 0.02% | 329 |
|
|
2021
Q1 | $1.54M | Hold |
58,000
| – | – | 0.04% | 299 |
|
|
2020
Q4 | $1.95M | Sell |
58,000
-56,000
| -49% | -$1.89M | 0.05% | 271 |
|
|
2020
Q3 | $3.48M | Sell |
114,000
-58,000
| -34% | -$1.77M | 0.12% | 187 |
|
|
2020
Q2 | $2.85M | Hold |
172,000
| – | – | 0.11% | 186 |
|
|
2020
Q1 | $1.61M | Hold |
172,000
| – | – | 0.09% | 204 |
|
|
2019
Q4 | $2.45M | Buy |
172,000
+131,000
| +320% | +$1.86M | 0.11% | 187 |
|
|
2019
Q3 | $605K | Hold |
41,000
| – | – | 0.03% | 307 |
|
|
2019
Q2 | $811K | Buy |
+41,000
| New | +$811K | 0.04% | 265 |
|